Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
Yadi Guan, Fang Han
Frontiers in Integrative Neuroscience (2020) Vol. 14
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation
Triveni Kodi, Runali Sankhe, Adarsh Gopinathan, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 22
Neuron-Astrocyte Interactions in Parkinson’s Disease
Ikuko Miyazaki, Masato Asanuma
Cells (2020) Vol. 9, Iss. 12, pp. 2623-2623
Open Access | Times Cited: 116
Regulated cell death: discovery, features and implications for neurodegenerative diseases
Juntao Cui, Suhan Zhao, Yinghui Li, et al.
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 73
Resveratrol Inhibits NLRP3 Inflammasome-Induced Pyroptosis and miR-155 Expression in Microglia Through Sirt1/AMPK Pathway
Kemal Uğur Tüfekçi, Bedir Irem Eltutan, Kamer Burak Isci, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 1812-1829
Closed Access | Times Cited: 54
MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes
Saba Bakhshi, Saeedeh Shamsi
International Immunopharmacology (2022) Vol. 106, pp. 108595-108595
Closed Access | Times Cited: 50
Salidroside Ameliorates Depression by Suppressing NLRP3-Mediated Pyroptosis via P2X7/NF-κB/NLRP3 Signaling Pathway
Yuhui Chai, Yawen Cai, Yu Fu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 49
NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
Qiu-Qin Han, Weidong Le
Neuroscience Bulletin (2023) Vol. 39, Iss. 5, pp. 832-844
Open Access | Times Cited: 32
Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases
Tingting Han, Yuxiang Xu, Lin Sun, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 6, pp. 1241-1248
Open Access | Times Cited: 21
Targeting Neuroinflammation by Pharmacologic Downregulation of Inflammatory Pathways Is Neuroprotective in Protein Misfolding Disorders
Sydney Risen, Sean W. Boland, Sadhana Sharma, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 7, pp. 1533-1547
Closed Access | Times Cited: 11
The Influence of Virus Infection on Microglia and Accelerated Brain Aging
Luis Filgueira, Alexey Larionov, Nils Lannes
Cells (2021) Vol. 10, Iss. 7, pp. 1836-1836
Open Access | Times Cited: 44
Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer’s Disease
Anna Litwiniuk, Wojciech Bik, Małgorzata Kalisz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5603-5603
Open Access | Times Cited: 42
The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
Ya-Shuo Feng, Zixuan Tan, Linyu Wu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111428-111428
Open Access | Times Cited: 41
Increased pyroptosis activation in white matter microglia is associated with neuronal loss in ALS motor cortex
Evelien Van Schoor, Simona Ospitalieri, Sebastiaan Moonen, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 3, pp. 393-411
Closed Access | Times Cited: 34
Research progress of targeting NLRP3 inflammasome in peripheral nerve injury and pain
Wei Li, Jie Liang, Shaohua Li, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109026-109026
Closed Access | Times Cited: 34
Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
An-Qi Dong, Yaping Yang, Shu-min Jiang, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 1, pp. 32-43
Open Access | Times Cited: 33
NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson's disease
Mayuri Khot, Anika Sood, Kamatham Pushpa Tryphena, et al.
European Journal of Pharmacology (2022) Vol. 934, pp. 175300-175300
Closed Access | Times Cited: 32
Polyphenols: Natural food grade biomolecules for treating neurodegenerative diseases from a multi-target perspective
Zhenmin Li, Ting Zhao, Mingqin Shi, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 17
Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer’s Disease
Yunfeng Li, Xiongjin Chen, Mulan Zhou, et al.
Journal of Alzheimer s Disease (2023) Vol. 97, Iss. 1, pp. 75-88
Closed Access | Times Cited: 16
Natural products target pyroptosis for ameliorating neuroinflammation: A novel antidepressant strategy
Guangheng Zhang, Ruirui Shang, Xia Zhong, et al.
Phytomedicine (2025) Vol. 138, pp. 156394-156394
Closed Access
1,2,4-Trimethoxybenzene ameliorates depression-like behaviors by inhibiting the activation of NLRP3 inflammasome
Yang Zhang, Na Che, Bo Wang, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114361-114361
Closed Access
Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases
Tuuli-Maria Sonninen, Gundars Goldsteins, Nihay Laham-Karam, et al.
Cells (2020) Vol. 9, Iss. 10, pp. 2183-2183
Open Access | Times Cited: 41
A mini-review on ion fluxes that regulate NLRP3 inflammasome activation
Chenguang Li, Mingye Chen, Xian‐Hui He, et al.
Acta Biochimica et Biophysica Sinica (2020) Vol. 53, Iss. 2, pp. 131-139
Open Access | Times Cited: 41
Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson’s disease model
Xiaofei Qiu, Qinghui Wang, Liyan Hou, et al.
Toxicology Letters (2021) Vol. 349, pp. 1-11
Closed Access | Times Cited: 37
Inflammasome Activation in Parkinson’s Disease
Shannon Jewell, Ashane M. Herath, Richard D. Gordon
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S113-S128
Open Access | Times Cited: 26
The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models
Laura Palumbo, Marianna Carinci, Annunziata Guarino, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2825-2825
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top